MENLO PARK, Calif.--(BUSINESS WIRE)--ReCode Therapeutics, a clinical-stage genetic medicines company using tissue-specific delivery to power the next wave of mRNA and gene correction therapeutics, ...
-Investment: Recode Edge offers pre-seed financing to select founders, focusing on early-stage innovators using AI in the life sciences. -Target Audience: Recode Edge is open to all founders of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results